Journal of Fungi (Jul 2022)

Mycetoma: Development of Diagnosis and Treatment

  • Xingpei Hao,
  • Marcus Cognetti,
  • Rhonda Burch-Smith,
  • Emerald O’Sullivan Mejia,
  • Gene Mirkin

DOI
https://doi.org/10.3390/jof8070743
Journal volume & issue
Vol. 8, no. 7
p. 743

Abstract

Read online

Mycetoma describes a heterogeneous group of cutaneous and subcutaneous infections caused by either fungi (eumycetomas) or bacteria (actinomycetomas). It is characterized by a triad of clinical symptoms: painless subcutaneous tumor-like swelling, multiple sinuses and fistulas, and discharged grains in pus. This predominantly affects the feet in more than 70% of patients. It is endemic in the “mycetoma belt” regions, including Africa, South America, and South Asia. Autochthonous mycetoma is rare in the United States of America (USA). We recently reported a Latin American immigrant with eumycetoma in the State of Maryland, USA. With millions of immigrants from endemic regions, the true number of mycetomas in the USA is most likely higher than currently recognized. With the aim to raise the awareness of clinicians about mycetoma, especially dermatologists and podiatrists, we update the development of the epidemiology, etiology, clinical presentations, pathogenesis, diagnosis, differential diagnosis, and treatment of mycetoma.

Keywords